Urgent: May 4 deadline for BSX investors who lost money in fraud lawsuit

LOS ANGELES – March 30, 2026 – Investors in Boston Scientific Corporation (NYSE: BSX) are being reminded by law firm Glancy Prongay Wolke & Rotter LLP about the approaching May 4, 2026 deadline to submit a lead plaintiff motion. This deadline pertains to a class action lawsuit initiated on behalf of individuals who acquired Boston Scientific securities during the period spanning July 23, 2025, through February 3, 2026.

Ranked Stocks data indicates Boston Scientific (BSX) currently holds an RS Score of 48.53, placing it in the 3.53rd percentile within both its country and sector. While the company demonstrates strength in Profitability, scoring 84.22, it shows weaker performance in other key areas, with Valuation at 13.21, Growth at 22.13, Momentum at 7.56, and EPS Revisions at 70.00. Want to discover which stocks rank the highest? Start your free 7-day trial at rankedstocks.com.